OneMedNet to implement 1-for-10 reverse stock split Monday

MINNEAPOLIS - OneMedNet Corporation (ONMD) announced it will execute a 1-for-10 reverse stock split on Monday, September 29, 2026. Stockholders approved the move at the company's annual meeting on September 18, 2026. The Board of Directors then set the final ratio within the approved range. Post-split trading is expected to commence Monday under the same symbol ONMD with a new CUSIP number 68270C 202.

Every ten shares will be merged into one share, without altering par value. This will lower outstanding shares from roughly 59,286,450 to about 5,928,645. The total authorized shares remain unchanged. OneMedNet aims to meet the minimum bid price requirement for continued Nasdaq Capital Market listing. The reverse split will adjust available shares under equity incentive plans and impact the exercise price and number of shares in restricted stock units, warrants, and other equity instruments.

No fractional shares will be issued, with any fractional shares rounded up. Continental Stock Transfer & Trust Company serves as the exchange agent and transfer agent. Shareholders with electronic holdings do not need to act to receive post-split shares. OneMedNet offers real-world data via its platform, catering to life sciences firms, medical device makers, and AI developers.